Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,500
Closed -$292K 2613
2022
Q4
$292K Sell
3,500
-300
-8% -$27K 0.01% 1558
2022
Q3
$368K Buy
3,800
+1,800
+90% +$215K 0.01% 1372
2022
Q2
$210K Buy
+2,000
New +$256K 0.01% 1616
2019
Q3
Sell
-1,800
Closed -$219K 2027
2019
Q2
$219K Buy
+1,800
New +$214K ﹤0.01% 1678
2018
Q4
Sell
-1,900
Closed -$237K 2114
2018
Q3
$237K Buy
+1,900
New +$210K ﹤0.01% 1961

Other funds holding AMED

Two Sigma Securities's AMED Position: Q2 2025 in Review

Two Sigma Securities sold out of Amedisys (AMED) in Q2 2025, closing a stake of 2,440 shares — an estimated $226K sold.

Two Sigma Securities first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $504K in Q3 2022. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Two Sigma Securities reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,440 Amedisys shares in Q2 2025, an estimated $226K.
  • Two Sigma Securities first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
  • Two Sigma Securities's Amedisys position peaked at $504K in Q3 2022.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.